US 11767358
Human antibodies to Bet v 1 and methods of use thereof
granted A61KA61K2039/505A61K39/395
Quick answer
US patent 11767358 (Human antibodies to Bet v 1 and methods of use thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Sep 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Sep 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 40
- CPC classes
- A61K, A61K2039/505, A61K39/395, A61P, A61P37/08